| Cholesterol Treatment Trialists'(CTT) Collaborators.The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease:metaanalysisof individual data from 27 randomised trials[J]. Lancet, 2012, 380:581-590. Amarenco P, Bogousslavsky J, Callahan A, et al.High-dose atorvastatin after stroke or transient ischemic attack[J]. N Engl J Med, 2006, 355:549-559. Johnson-Anuna LN, Eckert GP, Franke C, et al.Simvastatin protects neurons from cytotoxicity by upregulating Bcl-2 mRNA and protein[J]. J Neurochem,2007, 101:77-86. Landmesser U, Bahlmann F, Mueller M, et al.Simvastatin versus ezetimibe pleiotropic and lipidlowering effects on endothelial function in humans[J].Circulation, 2005, 111:2356-2363. Halcox JPJ, Deanfield JE. Beyond the laboratory clinical implicat ions for st at in pleiot ropy[J ].Circulation, 2004, 109(suppl II):II42-II48. Baryan HK, Allan SM, Vail A, et al. Systematic review and meta-analysis of the efficacy of statins in experimental stroke[J]. Int J Stroke, 2012, 7:150-156.. Lakhan SE, Bagchi S, Hofer M. Statins and clinical outcome of acute ischemic stroke:a systematic review[J]. Int Arch Med, 2010, 3:22-28. Biff i A, Devan WJ, Anderson CD, et al. Statin treatment and functional outcome after ischemic stroke:case-control and meta-analysis[J]. Stroke, 2011,42:1314-1319. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the Early Management of Patients With Acute Ischemic St roke. A Guideline for Healthca re Professionals From the American Heart Association/American Stroke Association[EB/OL]. (2013-1-31)[2013-2-15]. http://stroke.ahajournals.org/content/early/2013/01/31/STR.0b013e318284056a. Chróinín DN, Callaly EL, Duggan J, et al. Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke:The North Dublin population stroke study[J]. Stroke, 2011,42:1021-1029. Flint AC, Kamel H, Navi BB, et al. Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival[J]. Stroke, 2012,43:147-154. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke:A controlled randomized study[J]. Neurology, 2007, 69:904-910. Goldstein LB, Amarenco P, Zivin J, et al. Statin t r e atment a nd s t roke out come i n t he St roke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL) Trial[J]. Stroke, 2009, 40:3526-3531. Chróinín DN, Asplund K, Asberg S, et al. Statin therapy and outcome after ischemic stroke systematic review and meta-analysis of observational studies and randomized trials[J]. Stroke, 2013, 44:448-456. Mariucci G, Taha E, Tantucci M, et al. Intravenous administration of pravastatin immediately after middle cerebral artery occlusion reduces cerebral oedema in spontaneously hypertensive rats[J]. Eur J Pharmacol, 2011, 660:381-386. Kim HH, Sawada N, Soydan G, et al. Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection[J]. J Cereb Blood Flow Metab, 2008,28:1285-1293. Stach K, Nguyen XD, Lang S, et al. Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand[J]. Cardiol J, 2012, 19:20-28. Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates Type I I I nit r ic oxide synthase in t h rombocy t e s , de c r e a se s plat ele t a c t ivat ion, a n d p r o t e c t s f r om c e r e b r a l i s c h emi a i n normocholesterolemic mice[J]. Stroke, 2000, 31:2437-2449. Forteza A, Romano JG, Campo-Bustillo I, et al.High-dose atorvastatin enhances impaired cerebral vasomotor reactivity[J]. J Stroke Cerebrovasc Dis,2012, 21:487-492. Pantoni L, Sarti C, Inzitari D, et al. Cytokines and cell adhesion molecules in cerebral ischemia:experimental bases and therapeutic perspectives[J]. Arterioscler Thromb Vasc Bio, 1998, 18:503-513. Kimura M, Kurose I, Russell J, et al. Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats[J]. Arterioscler Thromb Vasc Biol, 1997, 17:1521-1526. Bevi la cqua MP, Pobe r JS, Maje au GR, et al.Interleukin 1(IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells[J]. J Exp Med, 1984,160:618-623. Stanislaus R, Pahan K, Singh AK, et al. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin[J]. Neurosci Lett, 1999, 269:71-74. Kalonia H, Kumar P, Kumar A, et al. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats[J]. Behav Brain Res,2011, 216:220-228. Mason PR, Walter MF, Day CA, et al. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reduct a se i n hibitor s cont r ibut e to dist i nct pharmacologic and pleiotropic actions[J]. Am J Cardiol, 2005, 96[5A]:11F-23F. Mason PR, Walter MF, Day CA, et al. Active met abolite of ator vast atin inhibits membrane cholesterol domain formation by an antioxidant mechanism[J]. J Biol Chem, 2006, 281:9337-9345. Ford AL, An HY, D'Angelo G, et al. Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke[J]. Stroke, 2011, 42:1307-1313. |
